Article
Identification of genetic variants in the human indoleamine 2,3-dioxygenase (IDO1) gene, which have altered enzyme activity.
Pharmacogenetics and genomics - 1 Jun 2009
Arefayene Million, Philips Santosh, Cao Donghua, Mamidipalli Sudharani, Desta Zeruesenay, Flockhart David A, Wilkes David S, Skaar Todd C
Abstract excerpt
OBJECTIVES: Indoleamine 2,3-dioxygenase (IDO), a rate-limiting enzyme in tryptophan catabolism, is a key regulator of immune tolerance. We identified genetic variations in the IDO1 gene and evaluated their functional activities using in-vitro transfection studies. METHODS: We resequenced the exons and the intron/exon borders of the IDO1 gene in 96 samples from the Coriell DNA Repository. To determine the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
